Graves Adrienne L Insider Trades

Insider Trading History

Track insider trading activity for Graves Adrienne L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 HROWM
Director
Holding Value $26k 1,000 shares
Last Trade
May 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26k 1,000 shares
$26.03
$26.03
Harrow- 8.625% NT REDEEM 30/04/2026 USD 25
Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 HROWL
Director
Holding Value $25.6k 1,000 shares
Last Trade
May 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25.6k 1,000 shares
$25.61
$25.61
Harrow
Harrow HROW
Director
Holding Value $34.7k 1,000 shares
Last Trade
May 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.1k 1,000 shares
$31.07
$34.69
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 HROWM
Director
Holding Value $191k 7,339 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 7,339 shares
$26.43
$26.03
Harrow
Harrow HROW
Director
Holding Value $255k 7,339 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 7,339 shares
$30.66
$34.69
Harrow- 8.625% NT REDEEM 30/04/2026 USD 25
Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 HROWL
Director
Holding Value $188k 7,339 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$186k 7,339 shares
$25.39
$25.61
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $440k 50,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$388k 44,000 shares
$8.82
$8.80
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $317k 36,000 shares
Last Trade
Jul 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$285k 36,000 shares
$7.91
$8.80
Harrow
Harrow HROW
Director
Holding Value $290k 8,347 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 8,347 shares
$17.97
$34.69
Harrow- 8.625% NT REDEEM 30/04/2026 USD 25
Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 HROWL
Director
Holding Value $214k 8,347 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209k 8,347 shares
$25.00
$25.61
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 HROWM
Director
Holding Value $217k 8,347 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 8,347 shares
$26.40
$26.03
Harrow
Harrow HROW
Director
Holding Value $108k 3,119 shares
Last Trade
Jan 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.3k 3,119 shares
$9.71
$34.69
Harrow- 8.625% NT REDEEM 30/04/2026 USD 25
Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 HROWL
Director
Holding Value $79.9k 3,119 shares
Last Trade
Jan 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75.4k 3,119 shares
$24.16
$25.61
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 HROWM
Director
Holding Value $81.2k 3,119 shares
Last Trade
Jan 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79.5k 3,119 shares
$25.48
$26.03
IVERIC bio
IVERIC bio ISEE
Director
Holding Value $0 0 shares
Last Trade
Jul 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.28M 132,274 shares
$39.95
$39.95
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $634k 72,000 shares
Last Trade
Jul 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$363k 72,000 shares
$5.04
$8.80
IVERIC bio
IVERIC bio ISEE
Director
Holding Value $300k 7,500 shares
Last Trade
May 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$277k 7,500 shares
$36.96
$39.95
IVERIC bio
IVERIC bio ISEE
Director
Holding Value $882k 22,088 shares
Last Trade
May 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$545k 14,588 shares
$37.36
$39.95
IVERIC bio
IVERIC bio ISEE
Director
Holding Value $0 0 shares
Last Trade
May 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$545k 14,588 shares
$37.36
$39.95
IVERIC bio
IVERIC bio ISEE
Director
Holding Value $926k 23,186 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$375k 37,774 shares
$9.94
$39.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up